Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 465
interventional 390
Observational 70
Registry 5

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 188
Behavioral 69
Drug|placebo 62
Other 17
Behavioral|Drug 14
Device 11
Drug|Other 10
Behavioral|Other 5
Procedure 4
Behavioral|Drug|Other 2
Combination Product 2
Other|Procedure 2
Behavioral|Dietary Supplement|Procedure 1
Device|Drug 1
Diagnostic Test 1
Drug|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 333
NA 13
Norway 7
Canada 6
Russian Federation 3
Taiwan 3
China 2
Finland 2
Lithuania 2
Malaysia 2
Sweden 2
Australia 1
Chile 1
France 1
Germany 1
Germany|Sweden|Austria|Czech Republic 1
Iran, Islamic Republic of 1
Netherlands 1
Switzerland 1
Ukraine 1
United Kingdom 1
United States|Austria|Canada 1
United States|Canada 1
United States|China 1
United States|Malaysia 1
United States|Russian Federation 1

Sites per Study

Site_count Study_Count
1 320
2 36
3 5
4 3
5 2
6 2
7 1
8 2
10 1
11 2
12 3
14 1
15 2
16 1
18 3
20 1
28 1
29 1
36 1
38 1
42 1

Phase

Phase Study_Count
Phase 2 110
N/A 107
Phase 3 50
Phase 1 46
Phase 4 40
Phase 1/Phase 2 16
Phase 2/Phase 3 14
Early Phase 1 7

Number of Arms

Number_of_Arms Count_of_Studies
1 46
2 182
3 42
4 24
5 10
6 2
7 3
8 2
12 1
15 1
NA 77

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 25.0000 4.0000 0.00000 6.00 0.00000 6.0000 0.00 0.000
1st Qu. 54.0000 37.0000 6.50000 11.75 0.00000 36.5000 52.25 36.250
Median 64.0000 67.0000 28.50000 20.00 17.50000 84.5000 167.00 60.000
Mean 123.8571 155.9813 40.04348 46.25 49.12037 111.5714 232.90 168.075
3rd Qu. 185.0000 180.0000 50.00000 79.00 58.25000 142.0000 296.75 208.750
Max. 300.0000 3144.0000 208.00000 151.00 382.00000 308.0000 1015.00 900.000

Trial Group Type

group_type Group_Count
Experimental 356
Active Comparator 236
Placebo Comparator 86
NA 77
No Intervention 38
Other 31
Sham Comparator 11

Intervention Model

intervention_model Study_Count
Parallel Assignment 209
Single Group Assignment 62
Crossover Assignment 55
NA 45
Factorial Assignment 16
Sequential Assignment 3

Primary Purpose

primary_purpose Study_Count
Treatment 310
Prevention 25
Health Services Research 15
Basic Science 14
NA 12
Other 8
Supportive Care 4
Device Feasibility 1
Diagnostic 1

Observational Studies

Studies by Country

Country Study_Count
United States 46
NA 13
France 4
Australia 1
Austria 1
Denmark 1
Italy 1
Malaysia 1
Norway 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 57
2 8
3 1
8 1
24 1
31 1
35 1

Enrollment Metrics

Measure Observational
Min 6.0
1st Qu 31.0
Median 128.0
Mean 327285.1
3rd Qu 523.0
Max 22375112.0

Observation Model

observational_model Study_Count
Cohort 36
Other 13
Case-Only 12
NA 5
Ecologic or Community 2
Case-Control 1
Case Control 1

Time Perspective

time_perspective Study_Count
Prospective 53
Cross-Sectional 9
Retrospective 7
Other 1

Registries

Studies by Country

Country Study_Count
France 1
Germany 1
Korea, Republic of 1
Sweden 1
United States 1

Sites per Study

Site_count Study_Count
1 4
18 1

Enrollment Metrics

Measure Registries
Min 60.0
1st Qu 100.0
Median 258.0
Mean 548.6
3rd Qu 325.0
Max 2000.0

Registry Model

observational_model Study_Count
Cohort 2
Other 2
Case-Control 1

Time Perspective

time_perspective Study_Count
Prospective 5

Follow-up

target_duration Study_Count
12 Months 2
24 Weeks 1
3 Months 1
36 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

nct_id brief_title link overall_status source primary_completion_date
NCT04413552 INDV-2000 First in Human https://ClinicalTrials.gov/show/NCT04413552 Recruiting Indivior Inc. 2020-12-01
NCT03918850 Medication Treatment for Opioid Use Disorder in Expectant Mothers https://ClinicalTrials.gov/show/NCT03918850 Recruiting University of Cincinnati 2023-12-31
NCT03911466 Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study https://ClinicalTrials.gov/show/NCT03911466 Recruiting University of Cincinnati 2023-12-31
NCT03718065 Impact of Lofexidine on Stress, Craving and Opioid Use https://ClinicalTrials.gov/show/NCT03718065 Recruiting Medical University of South Carolina 2024-04-01
NCT03684681 The Navigator Trial https://ClinicalTrials.gov/show/NCT03684681 Recruiting Rhode Island Hospital 2020-10-31
NCT03396276 Houston Emergency Opioid Engagement System https://ClinicalTrials.gov/show/NCT03396276 Recruiting The University of Texas Health Science Center, Houston 2020-11-01
NCT03377855 Addressing Origins of the Opioid Epidemic by Improving Prescribing for Opioid-Naive Patients https://ClinicalTrials.gov/show/NCT03377855 Completed Weill Medical College of Cornell University 2019-12-31
NCT03368794 Naloxone to TReatment Entry in the Emergency Setting https://ClinicalTrials.gov/show/NCT03368794 Recruiting Region Skane 2019-07-28
NCT03822962 Pain Management Following Sinus Surgery https://ClinicalTrials.gov/show/NCT03822962 Recruiting University of Nebraska 2020-12-31
NCT03363243 Advancing STOP: Self-regulation Therapy for Opioid Addiction and Pain https://ClinicalTrials.gov/show/NCT03363243 Recruiting University of Colorado, Denver 2021-03-31
NCT03345173 Facilitating Rapid Naltrexone Initiation https://ClinicalTrials.gov/show/NCT03345173 Recruiting New York State Psychiatric Institute 2021-10-31
NCT03334903 Gabapentin Regimens and Their Effects on Opioid Consumption https://ClinicalTrials.gov/show/NCT03334903 Completed Brigham and Women’s Hospital 2019-04-24
NCT03320889 Hepatitis C Education for Pregnant Women With Opiate Dependence - Phase 2 https://ClinicalTrials.gov/show/NCT03320889 Completed TriHealth Inc. 2019-08-26
NCT03306368 Youth Opioid Recovery Support: A Developmentally-specific Intervention for Home Delivery of Extended Release Naltrexone https://ClinicalTrials.gov/show/NCT03306368 Completed Potomac Health Foundations 2019-06-01
NCT03305666 Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures https://ClinicalTrials.gov/show/NCT03305666 Recruiting Denver Health and Hospital Authority 2020-04-30
NCT03287180 Adolescent Community Reinforcement Approach in Combination With Buprenorphine/Naloxone for Severe Opioid Use https://ClinicalTrials.gov/show/NCT03287180 Recruiting Emory University 2020-08-30
NCT03278496 Recovery Housing and Drug Abuse Treatment Outcome https://ClinicalTrials.gov/show/NCT03278496 Completed Johns Hopkins University 2008-06-30
NCT03235154 A Pilot Study of Treating HCV at a Psychiatrist-staffed Outpatient Addiction Clinic https://ClinicalTrials.gov/show/NCT03235154 Active, not recruiting Community Research Initiative of New England 2020-04-30
NCT03190954 Brain Dopaminergic Signaling in Opioid Use Disorders https://ClinicalTrials.gov/show/NCT03190954 Recruiting National Institutes of Health Clinical Center (CC) 2024-12-31
NCT03150173 Onsite Buprenorphine Treatment at Syringe Exchange Programs https://ClinicalTrials.gov/show/NCT03150173 Recruiting Montefiore Medical Center 2021-06-30
NCT03143855 Drug Interaction and Subjective Effects of Compounds for Opioid Use Disorder https://ClinicalTrials.gov/show/NCT03143855 Completed Virginia Commonwealth University 2019-04-05
NCT03134092 The Life STORRIED Study https://ClinicalTrials.gov/show/NCT03134092 Completed University of Pennsylvania 2019-08-07
NCT03129347 Pharmacokinetic Evaluation of Nalmefene Administered Intranasally to Healthy Volunteers https://ClinicalTrials.gov/show/NCT03129347 Completed National Institute on Drug Abuse (NIDA) 2017-06-09
NCT03089983 Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings https://ClinicalTrials.gov/show/NCT03089983 Recruiting Yale University 2022-04-30
NCT03048643 Combining Opioid Addiction Treatment Services With CARe for Infectious Endocarditis https://ClinicalTrials.gov/show/NCT03048643 Completed University of Kentucky 2018-10-02
NCT03015597 Pilot Study of Contingency Management for Smoking Cessation https://ClinicalTrials.gov/show/NCT03015597 Completed King’s College London 2017-09-30
NCT02997644 Impact of Different Educational Approaches on Post-operative Opiate Utilization After Elective Lower Extremity Surgery https://ClinicalTrials.gov/show/NCT02997644 Completed Brooke Army Medical Center 2019-04-30
NCT02978417 Feasibility Study of Extended-release Naltrexone (Vivitrol) in Drug Court Settings https://ClinicalTrials.gov/show/NCT02978417 Completed Duke University 2019-06-30
NCT02922959 A Tailored, Peer-delivered Intervention to Reduce Recurring Opioid Overdoses https://ClinicalTrials.gov/show/NCT02922959 Completed University of Cincinnati 2019-07-25
NCT02896296 Open-Label Treatment Extension Study https://ClinicalTrials.gov/show/NCT02896296 Completed Indivior Inc. 2017-08-23
NCT02867124 Long-acting Naltrexone for Pre-release Prisoners https://ClinicalTrials.gov/show/NCT02867124 Recruiting Friends Research Institute, Inc. 2020-08-31
NCT02804152 Program for Pain & Prescription Opioid Use in Pregnancy https://ClinicalTrials.gov/show/NCT02804152 Active, not recruiting Medical University of South Carolina 2019-01-31
NCT02801357 Study to Evaluate the Exposures of Lofexidine and Its Major Metabolites in Subjects Seeking Buprenorphine Dose Reduction https://ClinicalTrials.gov/show/NCT02801357 Completed US WorldMeds LLC 2016-08-31
NCT02774954 Change the Cycle: An RCT to Prevent Injection Initiation https://ClinicalTrials.gov/show/NCT02774954 Active, not recruiting University of Southern California 2018-12-31
NCT02750748 Pharmacokinetic Evaluation of Intranasal, Intramuscular, and Oral Naltrexone in Healthy Volunteers https://ClinicalTrials.gov/show/NCT02750748 Completed National Institute on Drug Abuse (NIDA) 2016-09-30
NCT02696096 Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence https://ClinicalTrials.gov/show/NCT02696096 Completed Butler Hospital 2020-02-29
NCT02674711 Study of Opioid Use After Lumbar and Cervical Spine Surgery https://ClinicalTrials.gov/show/NCT02674711 Completed Brooke Army Medical Center 2017-02-28
NCT02616523 Influence of Dexmedetomidine and Lidocaine on Opioid Consumption in Laparoscopic Intestine Resection https://ClinicalTrials.gov/show/NCT02616523 Completed University Medical Centre Ljubljana 2015-06-30
NCT02602795 Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence https://ClinicalTrials.gov/show/NCT02602795 Completed Rhode Island Hospital 2018-01-31
NCT02593474 Medication-Assisted Treatment for Youth With Substance Use Disorders https://ClinicalTrials.gov/show/NCT02593474 Completed New York State Psychiatric Institute 2018-04-30
NCT02586896 Comparing Interventions for Opioid Dependent Patients Presenting in Medical Emergency Departments https://ClinicalTrials.gov/show/NCT02586896 Completed NYU Langone Health 2019-04-23
NCT03098407 Opioid Dependence Treatment Therapies in Pregnancy https://ClinicalTrials.gov/show/NCT03098407 Active, not recruiting University of Pittsburgh 2019-10-09
NCT02526212 Buprenorphine Group Medical Visits in Primary Care https://ClinicalTrials.gov/show/NCT02526212 Completed Montefiore Medical Center 2019-05-31
NCT02572089 Pharmacokinetic Evaluation of Intranasal and Intramuscular Naloxone in Healthy Volunteers https://ClinicalTrials.gov/show/NCT02572089 Completed National Institute on Drug Abuse (NIDA) 2015-01-31
NCT00000319 Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2 https://ClinicalTrials.gov/show/NCT00000319 Completed Yale University NA
NCT03389750 A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists. https://ClinicalTrials.gov/show/NCT03389750 Recruiting New York State Psychiatric Institute 2020-12-31
NCT00023283 Counseling Conditions for Buprenorphine in a Primary Care Clinic - 1 https://ClinicalTrials.gov/show/NCT00023283 Completed Yale University 2003-12-31
NCT02548728 Oxytocin Treatment of Opioid Dependence https://ClinicalTrials.gov/show/NCT02548728 Completed University of North Carolina, Chapel Hill 2016-12-31
NCT00000216 Buprenorphine Maintenance for Cocaine Abusing Opioid Addicts - 1 https://ClinicalTrials.gov/show/NCT00000216 Completed Yale University NA
NCT02543944 Improving Treatment Outcomes for Prescription Opioid Dependence https://ClinicalTrials.gov/show/NCT02543944 Recruiting University of Arkansas 2020-06-30
NCT02539823 Acute and Short-term Effects of CBD on Cue-induced Craving in Drug-abstinent Heroin-dependent Humans https://ClinicalTrials.gov/show/NCT02539823 Completed Hurd,Yasmin, Ph.D. 2017-05-24
NCT02510014 Safety and Tolerability Study of Depot Buprenorphine in Treatment Seeking Subjects With Opioid Use Disorder https://ClinicalTrials.gov/show/NCT02510014 Completed Indivior Inc. 2017-01-31
NCT02502175 Comparing Opium Tincture (OT) With Methadone for Medication-assisted Treatment of Opioid Use Disorder https://ClinicalTrials.gov/show/NCT02502175 Completed University of British Columbia 2018-03-08
NCT02496403 Buprenorphine and Substance Abuse Services for Prescription Opioid Dependence https://ClinicalTrials.gov/show/NCT02496403 Completed Kaiser Permanente 2019-05-31
NCT02477267 Study of Buprenorphine-Naloxone Sublingual Spray and Suboxone® Sublingual Film in Healthy Volunteers https://ClinicalTrials.gov/show/NCT02477267 Completed INSYS Therapeutics Inc 2015-07-31
NCT02440152 The Effectiveness of Deep Brain Stimulation for Opioid Relapse Prevention https://ClinicalTrials.gov/show/NCT02440152 Recruiting Ruijin Hospital 2019-07-31
NCT02437344 Glutamatergic Modulation to Facilitate Naltrexone Initiation in Opioid Dependence https://ClinicalTrials.gov/show/NCT02437344 Completed New York State Psychiatric Institute 2016-12-31
NCT02411357 Improving Effective Contraceptive Use Among Opioid-maintained Women: Stage II https://ClinicalTrials.gov/show/NCT02411357 Active, not recruiting University of Vermont 2019-03-06
NCT02396979 Intervention of HIV, Drug Use and the Criminal Justice System in Malaysia https://ClinicalTrials.gov/show/NCT02396979 Completed Yale University 2014-12-31
NCT02372591 Study of the Treatment of Experimental Pain in Buprenorphine Maintained Persons With Chronic Musculoskeletal Pain https://ClinicalTrials.gov/show/NCT02372591 Completed Johns Hopkins University 2017-06-30
NCT02362256 The Comparison of Stress Response to Rapid Opioid Detoxification Applying Different Methods of Opioid Antagonism https://ClinicalTrials.gov/show/NCT02362256 Completed Vilnius University 2014-06-30
NCT02360007 Interim Buprenorphine: Leveraging Medication + Technology to Bridge Delays in Treatment Access https://ClinicalTrials.gov/show/NCT02360007 Completed University of Vermont Medical Center 2016-06-30
NCT02359006 The Effects of Minocycline in Opioid-maintained Patients https://ClinicalTrials.gov/show/NCT02359006 Completed Yale University 2017-04-19
NCT02357901 Treatment Seeking Participants With Opioid Use Disorders Assessing Tolerability of Depot Injections of Buprenorphine https://ClinicalTrials.gov/show/NCT02357901 Completed Indivior Inc. 2016-04-29
NCT02345655 On-site Evaluation of Substances Consumption on Opiate Maintenance https://ClinicalTrials.gov/show/NCT02345655 Recruiting University Hospital, Toulouse 2020-04-30
NCT02324725 Biomarkers of Injectable Extended Release Naltrexone Treatment https://ClinicalTrials.gov/show/NCT02324725 Active, not recruiting University of Pennsylvania 2021-10-31
NCT02294253 Buprenorphine/Naloxone Stabilization and Induction Onto Injection Naltrexone https://ClinicalTrials.gov/show/NCT02294253 Completed New York State Psychiatric Institute 2017-12-31
NCT02282306 Phone Interview to Prevent Recurring Opioid Overdoses https://ClinicalTrials.gov/show/NCT02282306 Completed University of Cincinnati 2015-02-28
NCT02252068 Study of Treatment for Opioid Dependence and Anxiety Disorders https://ClinicalTrials.gov/show/NCT02252068 Completed Mclean Hospital 2019-10-24
NCT02243670 Using Artificial Intelligence To Monitor Medication Adherence in Opioid Replacement Therapy https://ClinicalTrials.gov/show/NCT02243670 Completed AiCure 2017-03-31
NCT02200406 Desvenlafaxine in Opioid-Dependent Patients https://ClinicalTrials.gov/show/NCT02200406 Completed Centre hospitalier de l’Université de Montréal (CHUM) 2017-01-31
NCT02187198 Buprenorphine Treatment for Opioid Dependence https://ClinicalTrials.gov/show/NCT02187198 Active, not recruiting Yale University 2021-02-01
NCT02180659 A Study of Adult Outpatients With Opioid Dependence Transitioned From a Daily SL Buprenorphine to Probuphine® Subdermal Implants https://ClinicalTrials.gov/show/NCT02180659 Completed Titan Pharmaceuticals 2015-05-31
NCT02152397 Safety and Health Intervention Project https://ClinicalTrials.gov/show/NCT02152397 Completed University of Michigan 2016-12-31
NCT02093559 Repeated-dose Brief Intervention to Reduce Overdose and Risk Behaviors Among Naloxone Recipients https://ClinicalTrials.gov/show/NCT02093559 Completed San Francisco Department of Public Health 2016-12-31
NCT01315184 Study of Computer-Based Treatment for Drug Dependence https://ClinicalTrials.gov/show/NCT01315184 Completed Yale University 2011-07-31
NCT01311778 Study to Test the Safety and Efficacy of Cannabidiol as a Treatment Intervention for Opioid Relapse https://ClinicalTrials.gov/show/NCT01311778 Completed Hurd,Yasmin, Ph.D. 2011-10-31
NCT01275599 Drug-Drug Interaction Study Between Telaprevir and Buprenorphine https://ClinicalTrials.gov/show/NCT01275599 Completed Vertex Pharmaceuticals Incorporated 2011-04-30
NCT02038790 Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent Population https://ClinicalTrials.gov/show/NCT02038790 Completed Indivior Inc. 2013-11-30
NCT04454645 Intervening With Opioid-Dependent MothersMothers and Infants https://ClinicalTrials.gov/show/NCT04454645 Recruiting University of Delaware 2025-03-31
NCT01999946 Extended-Release Naltrexone Opioid Treatment at Jail Re-Entry https://ClinicalTrials.gov/show/NCT01999946 Active, not recruiting NYU Langone Health 2019-05-28
NCT01967641 Prescription Opioid Abuse Among Pain Patients: Predictors of Relapse https://ClinicalTrials.gov/show/NCT01967641 Completed New York State Psychiatric Institute 2011-06-30
NCT01965704 Can Ondansetron Prevent Neonatal Abstinence Syndrome (NAS) in Babies Born to Narcotic-dependent Women https://ClinicalTrials.gov/show/NCT01965704 Recruiting Stanford University 2021-03-30
NCT01913418 Clinical Efficacy and Serum Proteomic Profiling of Suan-Zao-Ren Tang for Sleep Disturbance During Methadone Maintenance https://ClinicalTrials.gov/show/NCT01913418 Completed China Medical University, Taiwan 2014-03-31
NCT01909076 Transforming Opioid Prescribing in Primary Care https://ClinicalTrials.gov/show/NCT01909076 Completed Boston Medical Center 2016-03-31
NCT01908842 Efficacy of BNX Sublingual Tablets Versus BNX Sublingual Film for Treatment of Opioid-Dependent Adults https://ClinicalTrials.gov/show/NCT01908842 Completed Orexo AB 2014-04-30
NCT01903005 Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Dependence https://ClinicalTrials.gov/show/NCT01903005 Completed Orexo AB 2014-09-30
NCT01895270 Improving Buprenorphine Detoxification Outcomes With Isradipine https://ClinicalTrials.gov/show/NCT01895270 Completed University of Arkansas 2016-04-30
NCT01895036 Nalrexone Facilitated Discontinuation of Buprenorphine https://ClinicalTrials.gov/show/NCT01895036 Completed New York State Psychiatric Institute 2013-09-30
NCT01894087 Safety & Prevention Outcomes Study https://ClinicalTrials.gov/show/NCT01894087 Completed University of Michigan 2015-01-31
NCT01882361 Opioid Relapse & HIV Risk: 48 Versus 24 Weeks of Injectable Extended Release Naltrexone https://ClinicalTrials.gov/show/NCT01882361 Active, not recruiting University of Pennsylvania 2020-07-31
NCT01880086 Clomiphene Citrate for the Treatment of Low Testosterone Associated With Chronic Opioid Pain Medication Administration https://ClinicalTrials.gov/show/NCT01880086 Completed Weill Medical College of Cornell University 2016-03-31
NCT01873989 Testosterone Replacement for Male Opioid Agonist Maintained Patients https://ClinicalTrials.gov/show/NCT01873989 Completed Yale University 2015-01-31
NCT01863251 Atomoxetine for ATS and Opioid Dependence During Buprenorphine Maintenance Treatment in Malaysia https://ClinicalTrials.gov/show/NCT01863251 Completed Yale University 2014-08-31
NCT01863186 Efficacy, Safety and Dose-Response Study Followed by Open-Label Study of Lofexidine Treatment of Opioid Withdrawal https://ClinicalTrials.gov/show/NCT01863186 Completed US WorldMeds LLC 2014-11-30
NCT01848054 Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence https://ClinicalTrials.gov/show/NCT01848054 Completed Orexo AB 2014-01-31
NCT01846481 A Randomized, 4-sequence, 2-period, Double-blind, Placebo Controlled Study With a DSM-IV-TR Diagnosis of Cocaine Abuse https://ClinicalTrials.gov/show/NCT01846481 Completed Indivior Inc. 2013-06-30
NCT01843751 Dane County Drug Court Study for Addicted Offenders https://ClinicalTrials.gov/show/NCT01843751 Completed University of Wisconsin, Madison 2016-02-29
NCT01820442 Pharmacokinetic & Pharmacodynamic Interaction of Lofexidine and Buprenorphine in Buprenorphine Maintained Patients https://ClinicalTrials.gov/show/NCT01820442 Completed US WorldMeds LLC 2013-09-30
NCT01779973 Remote Observed Dosing to Increase Suboxone Compliance https://ClinicalTrials.gov/show/NCT01779973 Completed University of Pennsylvania 2013-09-30
NCT01761110 Pilot Test of a Community-based Buprenorphine Treatment Intervention https://ClinicalTrials.gov/show/NCT01761110 Completed Albert Einstein College of Medicine 2014-02-28
NCT01759446 Abuse Potential of Intranasal VYCAVERT Tablets (Hydrocodone Bitartrate/Acetaminophen) in Recreational Opioid Users https://ClinicalTrials.gov/show/NCT01759446 Completed Acura Pharmaceuticals Inc. 2013-04-30
NCT01741350 Testing a Community-Friendly Risk Reduction Intervention for Injection Drug Users https://ClinicalTrials.gov/show/NCT01741350 Completed University of Connecticut 2011-05-31
NCT01740414 Effects of Ibudilast on Oxycodone Self-administration in Opioid Abusers https://ClinicalTrials.gov/show/NCT01740414 Completed New York State Psychiatric Institute 2015-12-31
NCT01738503 Multiple Dose Pharmacokinetics Depot Buprenorphine in Opioid-Dependent Subjects https://ClinicalTrials.gov/show/NCT01738503 Completed Indivior Inc. 2014-05-31
NCT01733693 Neurocognitive Effects of Opiate Agonist Treatment https://ClinicalTrials.gov/show/NCT01733693 Completed Albert Einstein College of Medicine 2017-06-30
NCT01728909 Methadone Oxytocin Option https://ClinicalTrials.gov/show/NCT01728909 Completed University of California, San Francisco 2014-10-31
NCT01718964 Acute Effects of Cortisol on Heroin Craving in Opioid Dependence (Ghost-Basel) https://ClinicalTrials.gov/show/NCT01718964 Completed University of Basel 2013-07-31
NCT01717963 Naltrexone vs Buprenorphine-Naloxone for Opioid Dependence in Norway https://ClinicalTrials.gov/show/NCT01717963 Completed University of Oslo 2016-08-31
NCT01690546 Low Dose Naltrexone-buprenorphine Transfer to Vivitrol Injection in Opioid Dependence https://ClinicalTrials.gov/show/NCT01690546 Completed Duke University 2015-02-28
NCT01666119 An Open Label Study To Assess The Safety And Tolerability Of BEMA® Buprenorphine NX In Opioid Dependent Subjects https://ClinicalTrials.gov/show/NCT01666119 Completed BioDelivery Sciences International 2013-01-31
NCT01650649 Main Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients https://ClinicalTrials.gov/show/NCT01650649 Completed US WorldMeds LLC 2012-12-31
NCT01645033 Computer-based Cognitive Behavioral Therapy for Risky Behaviors in Opioid Dependent Patients https://ClinicalTrials.gov/show/NCT01645033 Completed Yale University 2013-12-31
NCT01642030 Study of the Treatment of Experimental Pain in Opioid Dependent Persons on Methadone or Buprenorphine Maintenance https://ClinicalTrials.gov/show/NCT01642030 Completed Johns Hopkins University 2017-07-31
NCT01605539 Acute and Short-term Effects of Cannabidiol Admin on Cue-induced Craving in Drug-abstinent Heroin Dependent Humans https://ClinicalTrials.gov/show/NCT01605539 Completed Hurd,Yasmin, Ph.D. 2013-10-31
NCT01595867 Abuse Potential Assessment of Intranasally Administered EMBEDA Compared To Morphine Sulfate Controlled Release And Placebo https://ClinicalTrials.gov/show/NCT01595867 Completed Pfizer 2011-01-31
NCT01590251 Yoga for Pain and Opioid Dependence https://ClinicalTrials.gov/show/NCT01590251 Completed Yale University 2014-11-30
NCT01582347 Transfer of Subjects From Subutex/Suboxone to RBP-6300 https://ClinicalTrials.gov/show/NCT01582347 Completed Indivior Inc. 2012-11-30
NCT01558934 Pilot Study of Lofexidine and Methadone Pharmacodynamic Interaction in Methadone Maintained Patients https://ClinicalTrials.gov/show/NCT01558934 Completed US WorldMeds LLC 2012-04-30
NCT01556425 The Separate and Combined Effects of Vivitrol and Opiate Abstinence Reinforcement in the Treatment of Opioid Dependence https://ClinicalTrials.gov/show/NCT01556425 Completed Johns Hopkins University 2016-12-12
NCT01556087 Distress Tolerance and Buprenorphine https://ClinicalTrials.gov/show/NCT01556087 Completed Butler Hospital 2014-02-28
NCT01530542 A Clinical Study To Characterize The Pharmacokinetics And The Effects Of Food On Oxycodone In Healthy Volunteers https://ClinicalTrials.gov/show/NCT01530542 Completed Pfizer 2010-09-30
NCT01527994 Aprepitant Effects in Intravenous Heroin Dependence https://ClinicalTrials.gov/show/NCT01527994 Completed New York University 2014-06-30
NCT01512433 The Clinical Efficacy of Acupuncture as an Adjunct to Methadone Treatment Services for Heroin Addicts https://ClinicalTrials.gov/show/NCT01512433 Completed China Medical University, Taiwan 2012-03-31
NCT01505101 Mindfulness-Oriented Recovery Enhancement for Chronic Pain Patients Receiving Opioid Therapy https://ClinicalTrials.gov/show/NCT01505101 Completed Florida State University 2013-07-31
NCT01471145 Depot Naltrexone Mechanism of Action in Heroin Dependent Patients Using fMRI and SPECT https://ClinicalTrials.gov/show/NCT01471145 Completed Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2014-10-31
NCT01453374 A Study of VIVITROL in the Prevention of Re-arrest and Re-incarceration https://ClinicalTrials.gov/show/NCT01453374 Completed Alkermes, Inc. 2014-05-31
NCT01447212 Study to Assess Longer-term Opioid Medication Effectiveness (SALOME) https://ClinicalTrials.gov/show/NCT01447212 Completed University of British Columbia 2014-06-30
NCT01442493 Reengineering Methadone Treatment Study of Patient-centered Methadone Treatment https://ClinicalTrials.gov/show/NCT01442493 Completed Friends Research Institute, Inc. 2015-04-30
NCT01425060 Improving Effective Contraceptive Use Among Opioid-maintained Women https://ClinicalTrials.gov/show/NCT01425060 Completed University of Vermont 2014-06-30
NCT01416584 A Bridge to Treatment: The Therapeutic Workplace and Methadone Treatment https://ClinicalTrials.gov/show/NCT01416584 Completed Johns Hopkins University 2013-10-31
NCT01395784 Effects of Pioglitazone, a PPARgamma Receptor Agonist, on the Abuse Liability of Oxycodone https://ClinicalTrials.gov/show/NCT01395784 Completed New York State Psychiatric Institute 2014-01-31
NCT01393392 Developing a Smoking Cessation Intervention for Methadone Maintained Smokers https://ClinicalTrials.gov/show/NCT01393392 Completed Rutgers, The State University of New Jersey 2014-05-31
NCT01389180 Behavioral Drug and HIV Risk Reduction Counseling With MMT in China https://ClinicalTrials.gov/show/NCT01389180 Completed Yale University 2016-06-30
NCT01380093 Abuse Potential of Orally Administered Crushed Embeda Compared to Crushed Controlled-Release Morphine and Placebo in Non-Dependent Recreational Opioid Users https://ClinicalTrials.gov/show/NCT01380093 Completed Pfizer 2011-05-31
NCT01377610 Improved Strategies for Outpatient Opioid Detoxification https://ClinicalTrials.gov/show/NCT01377610 Completed New York State Psychiatric Institute 2017-12-31
NCT01376570 Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment https://ClinicalTrials.gov/show/NCT01376570 Completed Albert Einstein College of Medicine 2017-08-10
NCT01374763 A Comparison of PR Oxycodone/Naloxone and PR Oxycodone After Cardiac Surgery https://ClinicalTrials.gov/show/NCT01374763 Completed Tampere University Hospital 2011-12-31
NCT01344122 Medication-Assisted Treatment Implementation in Community Correctional Environments (MATICCE) https://ClinicalTrials.gov/show/NCT01344122 Completed Rhode Island Hospital 2013-09-30
NCT01334580 Cognitive-Behavioral Therapy for Pain and Opioid Dependence in Methadone Maintenance Treatment https://ClinicalTrials.gov/show/NCT01334580 Completed Yale University 2014-09-30
NCT04340622 Efficacy And Safety Of An Innovative Treatment Of Opiate Use Disorders https://ClinicalTrials.gov/show/NCT04340622 Recruiting MindLight, LLC 2020-12-15
NCT04272671 De-prescribing Program to Evaluate Falls in Older Adults https://ClinicalTrials.gov/show/NCT04272671 Recruiting University of North Carolina, Chapel Hill 2021-09-30
NCT04220489 Perioperative Ketamine in Opioid-Tolerant Patients Undergoing Lumbar Spine Surgery https://ClinicalTrials.gov/show/NCT04220489 Recruiting University of Pittsburgh 2020-06-30
NCT04189523 Does Early Administration of Ultrasound Guided Regional Anesthesia for Long Bone Fractures Effect Long Term Patient Opioid Usage https://ClinicalTrials.gov/show/NCT04189523 Recruiting Wayne State University 2020-06-30
NCT04080037 Assessing Opioid Care Practices Using CPV Patient Simulation Modules https://ClinicalTrials.gov/show/NCT04080037 Completed Qure Healthcare, LLC 2019-10-29
NCT04033562 The Analgesic Efficacy of Continuous Sub-fascial Bupivacaine Infusion and Lidocaine Patches in Post-cesarean Patients With Opiate Use Disorder: A Comparative Efficacy Analysis https://ClinicalTrials.gov/show/NCT04033562 Recruiting WellSpan Health 2021-09-01
NCT04018664 Oral Abuse Potential Study of Nalbuphine https://ClinicalTrials.gov/show/NCT04018664 Completed Trevi Therapeutics 2018-12-03
NCT04015115 Youth Opioid Recovery Support: Improving Care Systems https://ClinicalTrials.gov/show/NCT04015115 Active, not recruiting University of Maryland, Baltimore 2020-05-31
NCT03992079 A Multimodal Enhanced Recovery Program in Anorectal Surgery https://ClinicalTrials.gov/show/NCT03992079 Recruiting Columbia University 2020-07-31
NCT03971097 The Effect of Self-Forgiveness on Self-Stigma in Addiction. https://ClinicalTrials.gov/show/NCT03971097 Completed University of Pittsburgh 2019-12-01
NCT03950492 Feasibility of Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder https://ClinicalTrials.gov/show/NCT03950492 Recruiting West Virginia University 2020-12-30
NCT03949764 The Kentucky Viral Hepatitis Treatment Study https://ClinicalTrials.gov/show/NCT03949764 Recruiting University of Kentucky 2022-08-31
NCT03842137 tDCS to Decrease Opioid Relapse https://ClinicalTrials.gov/show/NCT03842137 Recruiting Butler Hospital 2023-12-31
NCT03838510 Repeated-dose Behavioral Intervention to Reduce Opioid Overdose https://ClinicalTrials.gov/show/NCT03838510 Recruiting San Francisco Department of Public Health 2022-12-31
NCT03837860 Reducing the Abuse of Opioids in Drug Users https://ClinicalTrials.gov/show/NCT03837860 Recruiting The University of Texas Health Science Center at San Antonio 2021-03-31
NCT03834025 Nudges and Incentives to Enhance the Opioid Treatment Workforce https://ClinicalTrials.gov/show/NCT03834025 Active, not recruiting University of North Carolina, Chapel Hill 2020-08-28
NCT03831113 Pharmacologically-based Strategies for Buprenorphine Treatment During Pregnancy https://ClinicalTrials.gov/show/NCT03831113 Recruiting University of Pittsburgh 2023-05-31
NCT03809143 Community Studies of Long Acting Buprenorphine (CoLAB) https://ClinicalTrials.gov/show/NCT03809143 Active, not recruiting The University of New South Wales 2020-11-01
NCT03798470 FAVOR Opioid Recovery Coaching Evaluation https://ClinicalTrials.gov/show/NCT03798470 Completed Prisma Health-Upstate 2018-12-31
NCT03791645 Evaluating The Efficacy Of A Mind-Body Intervention In Overcoming Opioid Addiction https://ClinicalTrials.gov/show/NCT03791645 Recruiting Ohio State University 2020-12-30
NCT03789214 Medical Management of Sleep Disturbance During Opioid Tapering https://ClinicalTrials.gov/show/NCT03789214 Recruiting Johns Hopkins University 2021-07-31
NCT03783702 Pain Control Following Sinus Surgery https://ClinicalTrials.gov/show/NCT03783702 Recruiting Stanford University 2019-10-01
NCT03779997 Trial of Adherence App for Buprenorphine Treatment (TAAB) Study https://ClinicalTrials.gov/show/NCT03779997 Active, not recruiting University of Washington 2020-05-15
NCT03773523 Neuromodulation and Cognitive Training in Opioid Use Disorder https://ClinicalTrials.gov/show/NCT03773523 Recruiting University of Minnesota 2021-10-31
NCT03769025 Remote Observed Dosing of Suboxone to Improve Clinical Practice https://ClinicalTrials.gov/show/NCT03769025 Active, not recruiting University of Pennsylvania 2022-12-31
NCT03681769 Developing Brain Stimulation as a Treatment for Chronic Pain in Opiate Dependent https://ClinicalTrials.gov/show/NCT03681769 Recruiting Medical University of South Carolina 2021-07-31
NCT03675386 Reducing Opioid Use for Chronic Pain Patients Following Surgery https://ClinicalTrials.gov/show/NCT03675386 Recruiting University Health Network, Toronto 2020-09-30
NCT03662529 Neurobehavioral Measurement of Substance Users in Outpatient Treatment Setting https://ClinicalTrials.gov/show/NCT03662529 Completed Hunter Holmes Mcguire Veteran Affairs Medical Center 2018-01-08
NCT03647774 Long Acting Naltrexone for Opioid Addiction: Focus on Sustained Abstinence and Recovery https://ClinicalTrials.gov/show/NCT03647774 Recruiting University Hospital, Akershus 2023-08-31
NCT03604159 XRB vs. SLB in Jail and at Re-entry: Pilot, Proof of Concept https://ClinicalTrials.gov/show/NCT03604159 Recruiting NYU Langone Health 2020-06-30
NCT03576781 Developing rTMS Treatment Strategies for Pain in Opiate Dependence https://ClinicalTrials.gov/show/NCT03576781 Completed Medical University of South Carolina 2019-11-12
NCT03575273 The Impact of Methadone Maintenance Therapy on Food Reward Processing in Opioid Dependence https://ClinicalTrials.gov/show/NCT03575273 Active, not recruiting Johns Hopkins University 2019-12-01
NCT03567356 Treatment of Opioid Use: Medication Adherence Therapy https://ClinicalTrials.gov/show/NCT03567356 Recruiting Potomac Health Foundations 2020-09-30
NCT03549312 Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy https://ClinicalTrials.gov/show/NCT03549312 Recruiting Saskatchewan Health Authority - Regina Area 2020-07-21
NCT03526380 The OPT-IN Project https://ClinicalTrials.gov/show/NCT03526380 Active, not recruiting University of Michigan 2020-06-30
NCT03521960 Buspirone for Opioid Tapering https://ClinicalTrials.gov/show/NCT03521960 Recruiting Johns Hopkins University 2020-05-30
NCT03475862 Nasal Human Abuse Potential of PTI-821 https://ClinicalTrials.gov/show/NCT03475862 Completed PainT 2017-07-31
NCT03447743 Re-entry XR-NTX for Rural Women With Opioid Use Disorder https://ClinicalTrials.gov/show/NCT03447743 Recruiting University of Kentucky 2021-03-31
NCT03411265 RETAIN: Retaining Opioid Users Entering Medication Assisted Treatment and Encouraging HCV/HIV Testing https://ClinicalTrials.gov/show/NCT03411265 Completed University of Cincinnati 2018-09-06
NCT01262261 Re-Treatment Study of Probuphine in Opioid Addiction https://ClinicalTrials.gov/show/NCT01262261 Completed Titan Pharmaceuticals 2011-11-30
NCT01262092 Effects of Gabapentin Versus Placebo on Buprenorphine Detoxification of Opioid-dependent Individuals https://ClinicalTrials.gov/show/NCT01262092 Completed University of Arkansas 2011-12-31
NCT01246401 Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations https://ClinicalTrials.gov/show/NCT01246401 Completed Yale University 2016-03-31
NCT01218984 ALK21-004: Single-dose Opiate Challenge of Medisorb® Naltrexone (VIVITROL®) in Adults Who Use Opioids https://ClinicalTrials.gov/show/NCT01218984 Completed Alkermes, Inc. 2003-05-31
NCT01188421 Medications Development for Drug Abuse Disorders https://ClinicalTrials.gov/show/NCT01188421 Completed Johns Hopkins University 2015-06-30
NCT01182402 Electronic Compliance Monitoring in Opioid Substitution Treatment https://ClinicalTrials.gov/show/NCT01182402 Completed Kuopio University Hospital 2011-02-28
NCT01180647 Extended-Release Naltrexone for Opioid Relapse Prevention Following Release From Jail https://ClinicalTrials.gov/show/NCT01180647 Completed NYU Langone Health 2013-07-31
NCT01136356 A Within Subject Comparison of Opioid Withdrawal in Opioid Dependent Individuals https://ClinicalTrials.gov/show/NCT01136356 Completed Johns Hopkins University 2012-03-31
NCT01114308 A Six-Month Randomized Controlled Trial (RCT) of Probuphine Safety and Efficacy in Opioid Addiction https://ClinicalTrials.gov/show/NCT01114308 Completed Titan Pharmaceuticals 2011-05-31
NCT01082679 Treatment for Opioid Dependent Offenders https://ClinicalTrials.gov/show/NCT01082679 Completed University of Wisconsin, Madison 2011-03-31
NCT01052662 Memantine-enhanced Buprenorphine Treatment for Opioid-dependent Young Adults https://ClinicalTrials.gov/show/NCT01052662 Completed University of Massachusetts, Worcester 2013-06-30
NCT01045278 Hepatitis C in a Cohort of Patients With Maintenance Therapy for Opiate Dependence - Prevalence, Severity and Outcome of Antiviral Therapy https://ClinicalTrials.gov/show/NCT01045278 Completed Region Skane 2013-09-30
NCT01030406 Study of the Relative Abuse Potential of Acurox Tablets in Non-Dependent Recreational Opioid Users https://ClinicalTrials.gov/show/NCT01030406 Completed Acura Pharmaceuticals Inc. 2010-02-28
NCT01024335 Dronabinol Naltrexone Treatment for Opioid Dependence https://ClinicalTrials.gov/show/NCT01024335 Completed New York State Psychiatric Institute 2012-12-31
NCT01004393 Methylnaltrexone for Opioid-induced Constipation in Cancer Patients https://ClinicalTrials.gov/show/NCT01004393 Completed University of Vermont 2013-12-31
NCT00999544 Aprepitant Effects on Oxycodone Response https://ClinicalTrials.gov/show/NCT00999544 Completed University of Kentucky 2011-04-30
NCT00992095 Bioequivalency Study of Buprenorphine Hydrochloride 8 mg Tablet Under Fasted Conditions https://ClinicalTrials.gov/show/NCT00992095 Completed West-Ward Pharmaceutical 2006-09-30
NCT00987961 Linking Hospitalized Injection Drug Users to Buprenorphine https://ClinicalTrials.gov/show/NCT00987961 Completed Butler Hospital 2014-03-31
NCT00929253 Efficacy of Computer Delivered Community Reinforcement Approach (CRA) (Bup II) https://ClinicalTrials.gov/show/NCT00929253 Completed Virginia Polytechnic Institute and State University 2010-04-30
NCT00913770 Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department https://ClinicalTrials.gov/show/NCT00913770 Completed Yale University 2013-08-31
NCT00901875 Multicentre Trial of Suboxone in Opiate-dependent Subjects in Taiwan https://ClinicalTrials.gov/show/NCT00901875 Completed Indivior Inc. 2009-11-30
NCT00879996 Buprenorphine and Methadone for Opioid Dependent Chronic Pain Patients https://ClinicalTrials.gov/show/NCT00879996 Completed State University of New York at Buffalo 2011-10-31
NCT00842036 CRAFT Behavior Therapy: Treatment Entry Component https://ClinicalTrials.gov/show/NCT00842036 Completed Treatment Research Institute 2009-12-31
NCT03241771 Impact of Direct Outreach to Expand Access to Naloxone in the Context of Standing Orders https://ClinicalTrials.gov/show/NCT03241771 Active, not recruiting Kaiser Permanente 2018-08-14
NCT00834080 ALK21-021: A Safety Study of Medisorb® Naltrexone (VIVITROL®) Administered to Health Care Professionals https://ClinicalTrials.gov/show/NCT00834080 Completed Alkermes, Inc. 2012-05-31
NCT00829777 Safety Study of Intravenous 6β-Naltrexol (AIKO-150) in Opioid-Dependent Subjects https://ClinicalTrials.gov/show/NCT00829777 Completed California Pacific Medical Center Research Institute 2009-09-30
NCT01550341 HIV, Buprenorphine, and the Criminal Justice System https://ClinicalTrials.gov/show/NCT01550341 Completed Yale University 2015-11-30
NCT01436474 Pilot Study of Varenicline to Treat Opioid Dependence https://ClinicalTrials.gov/show/NCT01436474 Completed Mayo Clinic 2012-09-30
NCT01389167 Naltrexone and Behavioral Drug and HIV Risk Reduction Counseling in Russia https://ClinicalTrials.gov/show/NCT01389167 Completed Yale University 2016-09-30
NCT04156802 Project Relief: Developing Brain Stimulation as a Treatment for Chronic Pain https://ClinicalTrials.gov/show/NCT04156802 Recruiting Wake Forest University Health Sciences 2021-12-31
NCT03891628 Modified ABC: A Home-based Parenting Program for Opioid-dependent Mothers and Their Infants https://ClinicalTrials.gov/show/NCT03891628 Recruiting University of Delaware 2025-03-31
NCT03538444 Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder https://ClinicalTrials.gov/show/NCT03538444 Recruiting Medical University of South Carolina 2021-06-01
NCT03155906 Integrated Treatment of Hepatitis C Virus Infection https://ClinicalTrials.gov/show/NCT03155906 Active, not recruiting Haukeland University Hospital 2020-05-08
NCT03022890 Study of Yoga vs. Health Education for Chronic Pain in Persons Receiving Opioid Agonist Therapy https://ClinicalTrials.gov/show/NCT03022890 Completed Butler Hospital 2018-11-16
NCT02992938 Administration of Acetazolamide to Prevent Remifentanil Induced Hyperalgesia https://ClinicalTrials.gov/show/NCT02992938 Completed University of Chile 2018-09-28
NCT02617628 Outcomes of Opioid Addicted Prisoners With Extended-Release Injectable Naltrexone https://ClinicalTrials.gov/show/NCT02617628 Completed University of Pennsylvania 2018-12-31
NCT02737696 Computer-based Prescription Opioid Abuse Prevention for Adolescents https://ClinicalTrials.gov/show/NCT02737696 Completed Dartmouth-Hitchcock Medical Center 2018-03-18
NCT03833245 Optimizing Pregnancy and Treatment Interventions for Moms 2.0 https://ClinicalTrials.gov/show/NCT03833245 Recruiting University of Utah 2022-02-28
NCT03610672 Mobile Intervention for Young Opioid Users https://ClinicalTrials.gov/show/NCT03610672 Recruiting National Development and Research Institutes, Inc. 2019-11-28
NCT03527485 Imaging Synaptic Density in Cocaine and Opiate Addiction In Vivo Using 11UCB-J PET https://ClinicalTrials.gov/show/NCT03527485 Active, not recruiting Yale University 2023-12-31
NCT00781898 Treatment Study Using Depot Naltrexone (1/6) Philadelphia Coord/Data Mgmt Site https://ClinicalTrials.gov/show/NCT00781898 Completed University of Pennsylvania 2015-08-31
NCT00780702 Aripiprazole for Prevention of Relapse to Cocaine Use in Methadone-Maintenance Patients https://ClinicalTrials.gov/show/NCT00780702 Completed National Institutes of Health Clinical Center (CC) 2013-04-16
NCT00763958 Relapse Prevention to Reduce HIV Among Women Prisoners https://ClinicalTrials.gov/show/NCT00763958 Completed University of Alabama at Birmingham 2009-09-30
NCT00757744 Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China https://ClinicalTrials.gov/show/NCT00757744 Completed Yale University 2010-01-31
NCT00756990 Depot Naltrexone Treatment of Opioid Dependent Parolees https://ClinicalTrials.gov/show/NCT00756990 Completed University of Pennsylvania 2009-03-31
NCT00734461 Study to Evaluate the Subjective Effects of PTI-801 in Non-Physically Dependent Subjects With a History of Drug Abuse https://ClinicalTrials.gov/show/NCT00734461 Completed PainT 2009-03-31
NCT00733239 Drug Discrimination in Methadone-Maintained Humans Study 2 https://ClinicalTrials.gov/show/NCT00733239 Completed University of Arkansas 2010-10-31
NCT00727675 Chronic Pain and Opioid Dependence Assessment and Treatment https://ClinicalTrials.gov/show/NCT00727675 Completed Yale University 2014-07-31
NCT00723177 Phase IIa Study of AV411, a Glial Activation Inhibitor, for Opioid Withdrawal https://ClinicalTrials.gov/show/NCT00723177 Completed New York State Psychiatric Institute 2010-04-30
NCT00719095 Effective Treatment for Prescription Opioid Abuse https://ClinicalTrials.gov/show/NCT00719095 Completed University of Vermont Medical Center 2010-03-31
NCT00718835 Incentive-based Smoking Cessation for Methadone Patients https://ClinicalTrials.gov/show/NCT00718835 Completed University of Vermont Medical Center 2013-06-30
NCT00712036 Entry Into Comprehensive Methadone Treatment Via Interim Maintenance https://ClinicalTrials.gov/show/NCT00712036 Completed Friends Research Institute, Inc. 2011-01-31
NCT00710385 Abuse Liability of Suboxone Versus Subutex https://ClinicalTrials.gov/show/NCT00710385 Completed New York State Psychiatric Institute 2008-08-31
NCT00699010 Study of the Abuse Liability of Oxycodone HCl/Niacin in Subjects With a History of Opioid Abuse https://ClinicalTrials.gov/show/NCT00699010 Completed Acura Pharmaceuticals Inc. 2008-08-31
NCT00684788 Employment-Based Depot Naltrexone Clinical Trial https://ClinicalTrials.gov/show/NCT00684788 Completed Johns Hopkins University 2009-05-31
NCT00684775 Employment-Based Depot Naltrexone Clinical Trial II https://ClinicalTrials.gov/show/NCT00684775 Completed Johns Hopkins University 2010-04-30
NCT00684554 Buprenorphine Maintenance Treatment of Opioid Dependence in Primary Care: A Randomized Clinical Trial https://ClinicalTrials.gov/show/NCT00684554 Completed New York State Psychiatric Institute 2008-08-31
NCT00684073 Preference for Subutex® (Buprenorphine) Versus Suboxone® (Buprenorphine/Naloxone) in Opioid Dependent Patients on Subutex® (Study P05094)(COMPLETED) https://ClinicalTrials.gov/show/NCT00684073 Completed Indivior Inc. 2007-12-31
NCT00678418 ALK21-013: Efficacy and Safety of Medisorb® Naltrexone (VIVITROL®) in Adults With Opioid Dependence https://ClinicalTrials.gov/show/NCT00678418 Completed Alkermes, Inc. 2009-10-31
NCT00640835 Safety and Tolerability of Buprenorphine/Naloxone Film Strips https://ClinicalTrials.gov/show/NCT00640835 Completed Indivior Inc. 2008-10-31
NCT00637000 Induction of Opioid-Dependent Individuals Onto Buprenorphine and Buprenorphine/Naloxone https://ClinicalTrials.gov/show/NCT00637000 Completed Indivior Inc. 2008-09-30
NCT00633243 Effective Treatment of Hepatitis C in Substance Users https://ClinicalTrials.gov/show/NCT00633243 Completed Yale University 2011-09-30
NCT00630201 Extension to Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence https://ClinicalTrials.gov/show/NCT00630201 Completed Titan Pharmaceuticals 2009-02-28
NCT00622596 Prospective Cohort of Opiate Dependent Patients on Buprenorphine/Naloxone for Maintenance https://ClinicalTrials.gov/show/NCT00622596 Completed Yale University 2008-09-30
NCT00605033 A Randomized Acceptability and Safety Study of the Transfer From Subutex to Suboxone in Opioid- Dependent Subjects (Study P04843)(COMPLETED) https://ClinicalTrials.gov/show/NCT00605033 Completed Indivior Inc. 2009-04-30
NCT00604188 A Randomized Acceptability and Safety Study of Suboxone Induction in Heroin Users (P05042)(COMPLETED) https://ClinicalTrials.gov/show/NCT00604188 Completed Merck Sharp & Dohme Corp. 2009-12-10
NCT00595764 Counseling for Primary Care Office-based Buprenorphine https://ClinicalTrials.gov/show/NCT00595764 Completed Yale University 2011-02-28
NCT00593125 Levetiracetam (Keppra) Tolerability in Cocaine Abusing Methadone-maintained Patients. https://ClinicalTrials.gov/show/NCT00593125 Completed National Institute on Drug Abuse (NIDA) 2007-08-31
NCT00591617 Optimizing Outcomes Using Suboxone for Opiate Dependence https://ClinicalTrials.gov/show/NCT00591617 Completed University of California, Los Angeles 2012-01-31
NCT00580827 Clinical Efficacy of Disulfiram in LAAM-Maintained Cocaine Abusers https://ClinicalTrials.gov/show/NCT00580827 Completed Yale University 2004-03-31
NCT00577408 Behavioral Naltrexone Therapy for Promoting Adherence to Oral Naltrexone vs Extended Release Injectable Depot Naltrexone https://ClinicalTrials.gov/show/NCT00577408 Completed New York State Psychiatric Institute 2011-08-31
NCT00566969 Cocaine Withdrawal and Pharmacotherapy Response https://ClinicalTrials.gov/show/NCT00566969 Completed Yale University 2012-12-31
NCT00555425 Buprenorphine Maintenance vs. Detoxification in Prescription Opioid Dependence https://ClinicalTrials.gov/show/NCT00555425 Completed Yale University 2013-05-31
NCT00548275 Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid Dependence https://ClinicalTrials.gov/show/NCT00548275 Completed Yale University 2011-06-30
NCT00521157 Naltrexone Implants as an Aid in Preventing Relapse Following Inpatient Treatment for Opioid Addiction https://ClinicalTrials.gov/show/NCT00521157 Completed University of Oslo 2008-06-30
NCT00499746 The Discriminative Effects of Tramadol in Humans https://ClinicalTrials.gov/show/NCT00499746 Completed National Institute on Drug Abuse (NIDA) 2010-04-30
NCT00476242 Memantine as a Supplement to Naltrexone in Treating Heroin Dependence https://ClinicalTrials.gov/show/NCT00476242 Completed New York State Psychiatric Institute 2011-08-31
NCT00475878 SSRI and Buprenorphine https://ClinicalTrials.gov/show/NCT00475878 Completed Butler Hospital 2009-09-30
NCT00460239 Buprenorphine’s Dose Response Curve https://ClinicalTrials.gov/show/NCT00460239 Completed Johns Hopkins University 2009-07-31
NCT00447564 Safety and Efficacy of Probuphine in the Treatment of Opioid Dependence https://ClinicalTrials.gov/show/NCT00447564 Completed Titan Pharmaceuticals 2008-07-31
NCT00439036 Acceptance Therapy During Methadone Detoxification https://ClinicalTrials.gov/show/NCT00439036 Completed The University of Texas Health Science Center, Houston 2010-08-31
NCT00420771 Gabapentin Treatment of Benzodiazepine Abuse in Methadone Maintenance Patients https://ClinicalTrials.gov/show/NCT00420771 Completed New York State Psychiatric Institute 2011-01-31
NCT00367302 Buprenorphine Maintenance for Opioid-Addicted Persons in Jail and Post-Release https://ClinicalTrials.gov/show/NCT00367302 Completed National Development and Research Institutes, Inc. 2008-01-31
NCT00406484 Brief Introductory Therapy for Opioid Dependence https://ClinicalTrials.gov/show/NCT00406484 Completed Yale University 2009-09-30
NCT00383045 HIV Risk Reduction and Drug Abuse Treatment in Malaysia https://ClinicalTrials.gov/show/NCT00383045 Completed Yale University NA
NCT00367874 Treatment of Polydrug-Using Opiate Dependents During Withdrawal https://ClinicalTrials.gov/show/NCT00367874 Completed Sorlandet Hospital HF NA
NCT00351026 Methadone Maintenance & HIV Risk in Ukraine https://ClinicalTrials.gov/show/NCT00351026 Completed University of Pennsylvania 2010-10-31
NCT00348868 Buprenorphine HIV Care Integration Project https://ClinicalTrials.gov/show/NCT00348868 Completed University of Miami 2007-12-31
NCT00344812 Opioid Maintenance Medications Comparison Study https://ClinicalTrials.gov/show/NCT00344812 Completed Johns Hopkins University NA
NCT00332228 Behavioral Naltrexone Therapy: A Novel Treatment for Heroin Dependence https://ClinicalTrials.gov/show/NCT00332228 Completed New York State Psychiatric Institute 2007-12-31
NCT00316277 Prescription Opioid Addiction Treatment Study (POATS) https://ClinicalTrials.gov/show/NCT00316277 Completed Mclean Hospital 2009-07-31
NCT00301210 Assessment of Tramadol as a Treatment for Opioid Addiction https://ClinicalTrials.gov/show/NCT00301210 Completed Johns Hopkins University 2007-10-31
NCT00300794 Effects of Ketamine On Precipitated Opioid Withdrawal Under General Anaesthesia https://ClinicalTrials.gov/show/NCT00300794 Completed Vilnius University NA
NCT00295308 Clonidine for Relapse Prevention in Buprenorphine-Maintenance Patients https://ClinicalTrials.gov/show/NCT00295308 Completed National Institutes of Health Clinical Center (CC) NA
NCT00292123 Combined Behavioral and Pharmacologic Treatment of Polydrug Abuse https://ClinicalTrials.gov/show/NCT00292123 Completed National Institute on Drug Abuse (NIDA) 2006-06-30
NCT00268814 The German Project of Heroin Assisted Treatment of Opiate Dependent Patients https://ClinicalTrials.gov/show/NCT00268814 Completed Universitätsklinikum Hamburg-Eppendorf 2003-12-31
NCT00271219 RCT Comparing Methadone and Buprenorphine in Pregnant Women https://ClinicalTrials.gov/show/NCT00271219 Completed Johns Hopkins University 2009-08-31
NCT00263458 Integrating Buprenorphine Into the SFGH AIDS Program https://ClinicalTrials.gov/show/NCT00263458 Completed University of California, San Francisco 2009-06-30
NCT00253890 Insomnia and Drug Relapse Risk https://ClinicalTrials.gov/show/NCT00253890 Completed Butler Hospital 2010-05-31
NCT00249587 Medication Adherence Therapy for Opioid Abusing Pain Patients https://ClinicalTrials.gov/show/NCT00249587 Completed National Institute on Drug Abuse (NIDA) 2005-09-30
NCT00249470 The Therapeutic Workplace Initiation Study https://ClinicalTrials.gov/show/NCT00249470 Completed Johns Hopkins University 2004-05-31
NCT00249457 Employment-based Reinforcement to Motivate Drug Abstinence in the Treatment of Drug Addiction. - 2 https://ClinicalTrials.gov/show/NCT00249457 Completed Johns Hopkins University 2006-01-31
NCT00241943 A Video-Based HCV Curriculum for Active Injection Drug Users https://ClinicalTrials.gov/show/NCT00241943 Completed Organization to Achieve Solutions in Substance Abuse (OASIS) 2007-08-31
NCT00241917 A Video-Based HCV Curriculum for Drug Users https://ClinicalTrials.gov/show/NCT00241917 Completed Organization to Achieve Solutions in Substance Abuse (OASIS) 2007-05-31
NCT00238914 Opiate Dependence: Combined Naltrexone/Behavior Therapy - 1 https://ClinicalTrials.gov/show/NCT00238914 Completed New York State Psychiatric Institute 2002-07-31
NCT00235729 Lofexidine for Inpatient Opiate Detox https://ClinicalTrials.gov/show/NCT00235729 Completed VA Office of Research and Development 2007-10-31
NCT00218608 Disulfiram for Treating Cocaine Dependence in Individuals Maintained on Methadone https://ClinicalTrials.gov/show/NCT00218608 Completed University of Arkansas 2007-01-31
NCT00218426 Addiction Treatment in Russia: Oral vs. Naltrexone Implant https://ClinicalTrials.gov/show/NCT00218426 Completed University of Pennsylvania 2009-06-30
NCT00218374 Dextromethorphan, Gabapentin, and Oxycodone to Treat Opioid-Induced Hyperalgesia https://ClinicalTrials.gov/show/NCT00218374 Completed National Institute on Drug Abuse (NIDA) 2007-06-30
NCT00218101 Buprenorphine as a Treatment for Individuals Dependent on Analgesic Opioids https://ClinicalTrials.gov/show/NCT00218101 Completed National Institute on Drug Abuse (NIDA) NA
NCT00204243 Naltrexone Implants vs. MMT Among Inmates in the Norwegian Correctional Services https://ClinicalTrials.gov/show/NCT00204243 Completed University of Oslo 2008-02-29
NCT00175357 NAOMI: A Study to Compare Medically-prescribed Heroin With Oral Methadone in Chronic Opiate Addiction https://ClinicalTrials.gov/show/NCT00175357 Completed University of British Columbia 2007-04-30
NCT00158288 The Efficacy of Methadyl Acetate (LAAM) and Contingency Management Procedures for Treating Dual Opioid and Cocaine Abuse - 1 https://ClinicalTrials.gov/show/NCT00158288 Completed National Institute on Drug Abuse (NIDA) NA
NCT00158236 Abuse Potential of Buprenorphine and Naloxone in Non-Dependent Opioid Users https://ClinicalTrials.gov/show/NCT00158236 Completed National Institute on Drug Abuse (NIDA) NA
NCT00158184 Prescription Opioid Effects in Abusers Versus Non-Abusers https://ClinicalTrials.gov/show/NCT00158184 Completed New York State Psychiatric Institute 2009-06-30
NCT00149669 Employment-based Reinforcement of Naltrexone Ingestion and Abstinence https://ClinicalTrials.gov/show/NCT00149669 Completed Johns Hopkins University 2010-12-31
NCT00149630 Pharmacogenetics of Disulfiram for Cocaine https://ClinicalTrials.gov/show/NCT00149630 Completed Baylor College of Medicine 2009-12-31
NCT00147784 HEPMET-1: Evaluate the Feasibility, Mental Sideeffects and the Efficacy of Hepatitis C Treatment in a MMT Group. https://ClinicalTrials.gov/show/NCT00147784 Completed Sorlandet Hospital HF 2007-06-30
NCT00142935 Effectiveness of Opiate Replacement Therapy Administered Prior to Release From a Correctional Facility - 1 https://ClinicalTrials.gov/show/NCT00142935 Completed The Miriam Hospital 2009-12-31
NCT00142909 Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1 https://ClinicalTrials.gov/show/NCT00142909 Completed Yale University 2009-01-31
NCT00142896 Tramadol to Reduce Opioid Withdrawal Symptoms https://ClinicalTrials.gov/show/NCT00142896 Completed National Institute on Drug Abuse (NIDA) 2005-12-31
NCT00142779 Fluoxetine to Reduce Cocaine Use in Cocaine and Opioid Addicts https://ClinicalTrials.gov/show/NCT00142779 Completed National Institute on Drug Abuse (NIDA) 2006-01-31
NCT00135759 Addition of Naltrexone to Methadone Taper https://ClinicalTrials.gov/show/NCT00135759 Completed National Institute on Drug Abuse (NIDA) NA
NCT00134914 Effects of Buprenorphine/Naloxone Administered in Different Ways For Treating Opioid Dependence https://ClinicalTrials.gov/show/NCT00134914 Completed National Institute on Drug Abuse (NIDA) 1998-04-30
NCT00134888 Blockade Efficacy of Buprenorphine/Naloxone For Opioid Dependence https://ClinicalTrials.gov/show/NCT00134888 Completed National Institute on Drug Abuse (NIDA) NA
NCT00130819 Comparison of HIV Clinic-based Treatment With Buprenorphine Versus Referred Care in Heroin-dependent Participants https://ClinicalTrials.gov/show/NCT00130819 Completed Johns Hopkins University 2009-04-30
NCT00129298 Effectiveness of Tiagabine for Cocaine Dependence in Methadone-Maintained Individuals - 1 https://ClinicalTrials.gov/show/NCT00129298 Completed National Institute on Drug Abuse (NIDA) NA
NCT00798538 Integration of Buprenorphine Into HIV Clinical Settings - Primary Care Model (PCM) https://ClinicalTrials.gov/show/NCT00798538 Completed Yale University 2010-08-31
NCT00125515 Memantine and Naltrexone Treatment for Opioid Dependence https://ClinicalTrials.gov/show/NCT00125515 Completed New York State Psychiatric Institute 2008-08-31
NCT00117741 Evaluation of DBT Compared to Drug Counseling for Opiate Addicts https://ClinicalTrials.gov/show/NCT00117741 Completed University of Washington 2008-10-31
NCT00078130 Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1 https://ClinicalTrials.gov/show/NCT00078130 Completed National Institute on Drug Abuse (NIDA) 2006-01-31
NCT00078117 Suboxone: (Buprenorphine/Naloxone) Comparison of Two Taper Schedules - 1 https://ClinicalTrials.gov/show/NCT00078117 Completed National Institute on Drug Abuse (NIDA) 2005-05-31
NCT00061100 HIV Counseling Intervention for Methadone-Maintained Patients - 2 https://ClinicalTrials.gov/show/NCT00061100 Completed New York State Psychiatric Institute 2003-10-31
NCT00061087 Treatment of Adult Attention Deficit Hyperactivity Disorder (ADHD) in Methadone Patients - 1 https://ClinicalTrials.gov/show/NCT00061087 Completed New York State Psychiatric Institute 2004-10-31
NCT00032942 Lofexidine for Opiate Withdrawal - 1 https://ClinicalTrials.gov/show/NCT00032942 Completed National Institute on Drug Abuse (NIDA) 2004-10-31
NCT00018226 Effect Of Case Management Following Discharge From Methadone Treatment https://ClinicalTrials.gov/show/NCT00018226 Completed VA Office of Research and Development NA
NCT00015340 Buprenorphine/Naloxone in the Treatment of Heroin Dependence - 14 https://ClinicalTrials.gov/show/NCT00015340 Completed National Institute on Drug Abuse (NIDA) 2001-08-31
NCT00015288 Buprenorphine and Naloxone Combination Study - 10 https://ClinicalTrials.gov/show/NCT00015288 Completed National Institute on Drug Abuse (NIDA) NA
NCT00007527 Determine the Safety of a Sublingual Tablet Formulation of Buprenorphine and Naloxone by Extending the Combination Tablet Availability to Physicians in Office-Based Practice https://ClinicalTrials.gov/show/NCT00007527 Completed VA Office of Research and Development NA
NCT00000254 Isoflurane at Subanesthetic Concentrations - 6 https://ClinicalTrials.gov/show/NCT00000254 Completed University of Chicago 1995-09-30
NCT00218127 Treatment of Opioid/Heroin Dependence: Comparison of Three Medication Dosing Regimens https://ClinicalTrials.gov/show/NCT00218127 Completed National Institute on Drug Abuse (NIDA) 2005-07-31
NCT00000358 Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 7 https://ClinicalTrials.gov/show/NCT00000358 Completed National Institute on Drug Abuse (NIDA) NA
NCT00000357 Buprenorphine Maintenance for Opiate Dependence - 6 https://ClinicalTrials.gov/show/NCT00000357 Completed National Institute on Drug Abuse (NIDA) 1993-08-31
NCT00000356 Evaluation of L-alpha-acetylmethadol (LAAM) in Methadone Patients - 5 https://ClinicalTrials.gov/show/NCT00000356 Completed National Institute on Drug Abuse (NIDA) 1992-08-31
NCT00000355 Effects of Buprenorphine and Naloxone in Opiate Addicts - 4 https://ClinicalTrials.gov/show/NCT00000355 Completed National Institute on Drug Abuse (NIDA) 1996-01-31
NCT00000354 Evaluation of Lofexidine for Treatment of Opioid Withdrawal - 3 https://ClinicalTrials.gov/show/NCT00000354 Completed National Institute on Drug Abuse (NIDA) 1997-09-30
NCT00000353 Trial of Buprenorphine/Naloxone for Opiate Dependence - 2 https://ClinicalTrials.gov/show/NCT00000353 Completed National Institute on Drug Abuse (NIDA) 1997-09-30
NCT00000352 Effects of Dextromethorphan on Opioid Tolerance in Methadone Patients - 1 https://ClinicalTrials.gov/show/NCT00000352 Completed National Institute on Drug Abuse (NIDA) 1998-02-28
NCT00000345 Evaluation of Lofexidine for Treatment of Opiate Withdrawal - 10 https://ClinicalTrials.gov/show/NCT00000345 Completed National Institute on Drug Abuse (NIDA) NA
NCT00000344 Buprenorphine/Naloxone for Treatment of Opiate Dependence - 9 https://ClinicalTrials.gov/show/NCT00000344 Completed National Institute on Drug Abuse (NIDA) NA
NCT00000341 Evaluation of Liquid vs. Tablet Buprenorphine - 6 https://ClinicalTrials.gov/show/NCT00000341 Completed National Institute on Drug Abuse (NIDA) NA
NCT00000335 Activity Monitoring Assessment of Opiate Withdrawal - 4 https://ClinicalTrials.gov/show/NCT00000335 Completed National Institute on Drug Abuse (NIDA) 1996-03-20
NCT00000334 Comparison of Buprenorphine and Methadone - 3 https://ClinicalTrials.gov/show/NCT00000334 Completed National Institute on Drug Abuse (NIDA) 2004-11-01
NCT00000320 Buprenorphine Formulation Comparison: Sublingual Tablet vs. Solution - 1 https://ClinicalTrials.gov/show/NCT00000320 Completed National Institute on Drug Abuse (NIDA) 1999-08-31
NCT00000318 Buprenorphine Maintenance Dose Schedule and Treatment Setting - 1 https://ClinicalTrials.gov/show/NCT00000318 Completed National Institute on Drug Abuse (NIDA) 2004-03-31
NCT00000311 Combining Behavioral Treatment With Agonist Maintenance - 1 https://ClinicalTrials.gov/show/NCT00000311 Completed Yale University 1999-02-28
NCT00000306 Dextroamphetamine as Adjunct in Cocaine/Opiate Dependent Patients - 3 https://ClinicalTrials.gov/show/NCT00000306 Completed National Institute on Drug Abuse (NIDA) NA
NCT00000300 Feasibility Study of Take-Home LAAM Medication - 3 https://ClinicalTrials.gov/show/NCT00000300 Completed University of California, Los Angeles NA
NCT00000299 Rapid Opiate Detoxification and Naltrexone Induction Using Buprenorphine - 2 https://ClinicalTrials.gov/show/NCT00000299 Completed University of California, Los Angeles 2009-11-30
NCT00000298 Buprenorphine Combination Tablet Feasibility - 1 https://ClinicalTrials.gov/show/NCT00000298 Completed National Institute on Drug Abuse (NIDA) NA
NCT00000279 Novel Medications for Opiate Detoxification - 4 https://ClinicalTrials.gov/show/NCT00000279 Completed Yale University 1999-08-31
NCT00000273 A Laboratory Model for Heroin Abuse Medications - 8 https://ClinicalTrials.gov/show/NCT00000273 Completed New York State Psychiatric Institute 2005-11-30
NCT00000264 Subjective/Psychomotor/ Effects of Combined Alcohol & Nitrous Oxide - 16 https://ClinicalTrials.gov/show/NCT00000264 Completed University of Chicago 1999-10-31
NCT00000263 Effects of Combined Alcohol and Nitrous Oxide Intake - 15 https://ClinicalTrials.gov/show/NCT00000263 Completed University of Chicago 1998-10-31
NCT00000262 Effects of Combined Sevoflurane and Nitrous Oxide Inhalation - 14 https://ClinicalTrials.gov/show/NCT00000262 Completed University of Chicago 1999-02-28
NCT00000261 Effects of Alcohol History on Effects of Sevoflurane and Nitrous Oxide - 13 https://ClinicalTrials.gov/show/NCT00000261 Completed University of Chicago 1998-10-31
NCT00000260 Effects of Behavioral Contingencies on Effects of Nitrous Oxide - 12 https://ClinicalTrials.gov/show/NCT00000260 Completed University of Chicago 1998-01-31
NCT00000259 Sevoflurane vs Nitrous Oxide Inhalation at Subanesthetic Concentrations - 11 https://ClinicalTrials.gov/show/NCT00000259 Completed University of Chicago 1997-11-30
NCT00000258 Role of Instructions in Nitrous Oxide Effects and Choice - 10 https://ClinicalTrials.gov/show/NCT00000258 Completed University of Chicago 1997-11-30
NCT00000257 Effects of Alcohol History on Effects of Nitrous Oxide - 9 https://ClinicalTrials.gov/show/NCT00000257 Completed University of Chicago 1997-04-30
NCT00000256 Reinforcing Effects of Brief Exposures to Nitrous Oxide - 8 https://ClinicalTrials.gov/show/NCT00000256 Completed University of Chicago 1996-11-30
NCT00000255 Differential Acute Tolerance Development to Effects of Nitrous Oxide - 7 https://ClinicalTrials.gov/show/NCT00000255 Completed University of Chicago 1996-05-31
NCT00000253 Effects of Nitrous Oxide: A Dose-Response Analysis - 5 https://ClinicalTrials.gov/show/NCT00000253 Completed University of Chicago 1996-03-31
NCT00000252 Lack of Acute Tolerance Development to Effects of Nitrous Oxide - 4 https://ClinicalTrials.gov/show/NCT00000252 Completed University of Chicago 1996-06-30
NCT00000251 Effects of Subanesthetic Concentrations of Isoflurane/Nitrous Oxide - 3 https://ClinicalTrials.gov/show/NCT00000251 Completed University of Chicago 1996-01-31
NCT00000250 Cold Water Immersion Modulates Reinforcing Effects of Nitrous Oxide - 2 https://ClinicalTrials.gov/show/NCT00000250 Completed University of Chicago 1995-05-31
NCT00000249 Effects of Subanesthetic Concentrations of Nitrous Oxide - 1 https://ClinicalTrials.gov/show/NCT00000249 Completed University of Chicago 1995-06-30
NCT00000244 Effects of Dynorphin 1-13 on Heroin Addiction - 1 https://ClinicalTrials.gov/show/NCT00000244 Completed University of Minnesota 1997-03-31
NCT00000240 Combined Buprenorphine and Behavioral Treatment With and Without Contingent Reinforcement on Opioid and Cocaine Abstinence. - 22 https://ClinicalTrials.gov/show/NCT00000240 Completed University of Vermont NA
NCT00000239 Buprenorphine Pharmacology Related to Addiction Treatment - 21 https://ClinicalTrials.gov/show/NCT00000239 Completed National Institute on Drug Abuse (NIDA) NA
NCT00000238 Temporal Discounting Delayed Outcomes on Opioid-Dependent Outpatients - 20 https://ClinicalTrials.gov/show/NCT00000238 Completed National Institute on Drug Abuse (NIDA) NA
NCT00000237 Buprenorphine Detoxification - BBDVI - 19 https://ClinicalTrials.gov/show/NCT00000237 Completed National Institute on Drug Abuse (NIDA) NA
NCT00000236 Buprenorphine Pharmacology Related to Addiction Treatment - 18 https://ClinicalTrials.gov/show/NCT00000236 Completed National Institute on Drug Abuse (NIDA) NA
NCT00000235 Alternate Day Buprenorphine Administration, Phase XII - 17 https://ClinicalTrials.gov/show/NCT00000235 Completed National Institute on Drug Abuse (NIDA) NA
NCT00000234 Alternate Day Buprenorphine Administration, Phase XI - 16 https://ClinicalTrials.gov/show/NCT00000234 Completed University of Vermont NA
NCT00000233 Alternate Day Buprenorphine Administration, Phase X - 15 https://ClinicalTrials.gov/show/NCT00000233 Completed National Institute on Drug Abuse (NIDA) NA
NCT00000232 Alternate Day Buprenorphine Administration, Phase IX - 14 https://ClinicalTrials.gov/show/NCT00000232 Completed University of Vermont NA
NCT00000231 Buprenorphine Detoxification With Two Types of Treatment. BBD IV - 13 https://ClinicalTrials.gov/show/NCT00000231 Completed National Institute on Drug Abuse (NIDA) NA
NCT00000230 Buprenorphine Detoxification With Two Types of Treatment. BBD III - 12 https://ClinicalTrials.gov/show/NCT00000230 Completed University of Vermont NA
NCT00000229 Buprenorphine Detox With Two Types of Treatment. BBD II - 11 https://ClinicalTrials.gov/show/NCT00000229 Completed University of Vermont NA
NCT00000228 Buprenorphine Detox With Two Types of Treatment. BBD I - 10 https://ClinicalTrials.gov/show/NCT00000228 Completed National Institute on Drug Abuse (NIDA) NA
NCT00000227 Alternate-Day Buprenorphine Administration. Phase VIII - 9 https://ClinicalTrials.gov/show/NCT00000227 Completed University of Vermont NA
NCT00000226 Alternate-Day Buprenorphine Administration. Phase VII - 8 https://ClinicalTrials.gov/show/NCT00000226 Completed National Institute on Drug Abuse (NIDA) NA
NCT00000225 Alternate-Day Buprenorphine Administration. Phase VI - 7 https://ClinicalTrials.gov/show/NCT00000225 Completed National Institute on Drug Abuse (NIDA) NA
NCT00000224 Alternate-Day Buprenorphine. Phase V - 6 https://ClinicalTrials.gov/show/NCT00000224 Completed National Institute on Drug Abuse (NIDA) NA
NCT00000223 Alternate-Day Buprenorphine Administration. Phase IV - 5 https://ClinicalTrials.gov/show/NCT00000223 Completed National Institute on Drug Abuse (NIDA) NA
NCT00000222 Alternate-Day Buprenorphine Administration. Phase II - 4 https://ClinicalTrials.gov/show/NCT00000222 Completed National Institute on Drug Abuse (NIDA) NA
NCT00000221 Alternate-Day Buprenorphine Administration. Phase I - 3 https://ClinicalTrials.gov/show/NCT00000221 Completed National Institute on Drug Abuse (NIDA) NA
NCT00000220 Gradual Vs. Rapid Buprenorphine Detoxification - 2 https://ClinicalTrials.gov/show/NCT00000220 Completed National Institute on Drug Abuse (NIDA) NA
NCT00000219 Buprenorphine Dose Alteration Study - 1 https://ClinicalTrials.gov/show/NCT00000219 Completed University of Vermont NA
NCT00015171 Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1 https://ClinicalTrials.gov/show/NCT00015171 Completed National Institute on Drug Abuse (NIDA) 1997-05-31
NCT00015041 Buprenorphine Dose Escalation Trial for Treatment of Non-Dependent Opiate Users - 2 https://ClinicalTrials.gov/show/NCT00015041 Completed National Institute on Drug Abuse (NIDA) 1998-06-30
NCT00015028 Buprenorphine/Naloxone for Opiate-Dependence Treatment - 1 https://ClinicalTrials.gov/show/NCT00015028 Completed National Institute on Drug Abuse (NIDA) 1996-12-31
NCT00000209 Buprenorphine Dosing Interval - 5 https://ClinicalTrials.gov/show/NCT00000209 Completed National Institute on Drug Abuse (NIDA) NA
NCT00000208 Methadone/Buprenorphine Cross-Over Study - 4 https://ClinicalTrials.gov/show/NCT00000208 Completed National Institute on Drug Abuse (NIDA) NA
NCT00000207 Multicenter Clinical Trial of Buprenorphine - 3 https://ClinicalTrials.gov/show/NCT00000207 Completed University of California, Los Angeles 1997-04-30
NCT00000206 Clinical Rescue Protocol - 2 https://ClinicalTrials.gov/show/NCT00000206 Completed University of California, Los Angeles 2005-08-31
NCT00000205 Buprenorphine Maintenance Protocol - 1 https://ClinicalTrials.gov/show/NCT00000205 Completed University of California, Los Angeles 1993-03-31
NCT00000204 Buprenorphine Maintenance for Opioid Addicts - 3 https://ClinicalTrials.gov/show/NCT00000204 Completed Yale University 2006-05-31
NCT00000203 Buprenorphine Maintenance for Opioid Addicts - 2 https://ClinicalTrials.gov/show/NCT00000203 Completed Yale University 2006-05-31
NCT00000202 Buprenorphine Maintenance for Opioid Addicts - 1 https://ClinicalTrials.gov/show/NCT00000202 Completed Yale University 2006-05-31

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03245931 Hepatitis C Education for Pregnant Women With Opiate Addiction - Phase 1 https://ClinicalTrials.gov/show/NCT03245931 Completed TriHealth Inc. 2019-08-26
NCT03036917 Cognitive Function Before and After Opioid Reduction in Patients With Chronic Pain https://ClinicalTrials.gov/show/NCT03036917 Completed Zealand University Hospital 2019-05-03
NCT02941809 Harnessing Placebo Effects in Methadone Treatment https://ClinicalTrials.gov/show/NCT02941809 Enrolling by invitation University of Maryland, Baltimore 2020-07-31
NCT02797990 Conflict Between Maternal Autonomy and Child Health in Substance-use https://ClinicalTrials.gov/show/NCT02797990 Completed London School of Hygiene and Tropical Medicine 2016-08-31
NCT02751762 A Prospective Investigation of the Risks of Opioid Misuse, Abuse, and Addiction Among Patients Treated With Opioids for the Treatment of Chronic Pain https://ClinicalTrials.gov/show/NCT02751762 Recruiting Member Companies of the Opioid PMR Consortium 2020-10-31
NCT02718352 A Naturalistic Study of Adolescents and Young Adults in Treatment for Opioid Dependence https://ClinicalTrials.gov/show/NCT02718352 Completed Yale University 2018-02-28
NCT02678507 A Quantitative Study to Assess the Construct Validity of the Prescription Opioid Misuse and Abuse Questionnaire https://ClinicalTrials.gov/show/NCT02678507 Completed Member Companies of the Opioid PMR Consortium 2017-06-21
NCT02668549 Cross-Sectional Study to Define and Validate “Doctor/Pharmacy Shopping” as Outcomes Suggestive of Abuse and/or Addiction https://ClinicalTrials.gov/show/NCT02668549 Completed Member Companies of the Opioid PMR Consortium 2017-08-09
NCT02667262 An Observational Study to Develop Algorithms for Identifying Opioid Abuse and Addiction Based on Admin Claims Data https://ClinicalTrials.gov/show/NCT02667262 Completed Member Companies of the Opioid PMR Consortium 2017-05-17
NCT02667210 Study to Eval Relation Btw Doctor/Pharmacy Shopping & Outcomes of Misuse, Diversion, Abuse, Addiction by Med Rec Review https://ClinicalTrials.gov/show/NCT02667210 Completed Member Companies of the Opioid PMR Consortium 2017-06-21
NCT02667197 Study to Validate Coded Medical Terms Used to Identify Opioid-Related Overdose in Databases Used for PMR Study 1B https://ClinicalTrials.gov/show/NCT02667197 Completed Member Companies of the Opioid PMR Consortium 2017-05-17
NCT02667158 A Survey to Eval the Relation Between Doctor/Pharmacy Shopping and Outcomes Suggestive of Misuse, Abuse and/or Diversion https://ClinicalTrials.gov/show/NCT02667158 Completed Member Companies of the Opioid PMR Consortium 2018-12-19
NCT02660619 Validation of PRISM-5-Op, Measure Of Addiction To Prescription Opioid Medication https://ClinicalTrials.gov/show/NCT02660619 Completed Member Companies of the Opioid PMR Consortium 2017-11-28
NCT02657148 Immediate Postpartum Nexplanon Placement in Opioid Dependent Women https://ClinicalTrials.gov/show/NCT02657148 Completed University of Pittsburgh 2018-08-31
NCT02583243 Project BEST: Buprenorphine Entry Into Substance Abuse Treatment https://ClinicalTrials.gov/show/NCT02583243 Completed Yale University 2008-08-31
NCT02571400 Prevalence and Predictors of Prolonged Post-surgical Opioid Use: a Prospective Observational Cohort Study https://ClinicalTrials.gov/show/NCT02571400 Completed University of Notre Dame Australia 2016-10-31
NCT02247024 Pupil Response in Patients on Opioids. https://ClinicalTrials.gov/show/NCT02247024 Completed Oslo University Hospital 2018-08-31
NCT02120612 Increasing Patient Knowledge of the Signs of Opioid Overdose and Naloxone in a Suburban Treatment Program https://ClinicalTrials.gov/show/NCT02120612 Recruiting Edward-Elmhurst Health System 2020-10-31
NCT02017041 Using mHealth to Aid Opioid Medication Adherence Pilot Study https://ClinicalTrials.gov/show/NCT02017041 Completed Care Team Solutions 2014-06-30
NCT01940588 Neuropsychoanalytic Treatment of Failed Back Surgery Syndrome-Opioid Dependence https://ClinicalTrials.gov/show/NCT01940588 Completed State University of New York - Upstate Medical University 2013-06-30
NCT01722435 Completion of OST - a Prospective Study https://ClinicalTrials.gov/show/NCT01722435 Completed Universitätsklinikum Hamburg-Eppendorf 2014-02-28
NCT01592461 Starting Treatment With Agonist Replacement Therapies Follow-up Study https://ClinicalTrials.gov/show/NCT01592461 Completed University of California, Los Angeles 2016-08-31
NCT01570699 Variation of COMT Val158Met Polymorphism Between COM-ON Patients and METHADOSE Patients https://ClinicalTrials.gov/show/NCT01570699 Completed Assistance Publique - Hôpitaux de Paris 2016-06-30
NCT01558973 FMRI of Stress and Addictive Disorders https://ClinicalTrials.gov/show/NCT01558973 Completed Yale University 2015-12-31
NCT01536925 Studies of Opioid Seeking Behavior: Yohimbine and Hydrocortisone Effects https://ClinicalTrials.gov/show/NCT01536925 Completed Wayne State University 2017-04-30
NCT01422837 ALK21-025: Vivitrol’s Cost and Treatment Outcomes Registry https://ClinicalTrials.gov/show/NCT01422837 Completed Alkermes, Inc. 2013-10-31
NCT04251208 MOms in REcovery (MORE) Study: Defining Optimal Care https://ClinicalTrials.gov/show/NCT04251208 Recruiting Trustees of Dartmouth College 2021-10-31
NCT04059016 Innovatively Increasing PCP Prescribing of Buprenorphine: Measurement Based Care and Integrated Electronic Solution https://ClinicalTrials.gov/show/NCT04059016 Active, not recruiting University of Texas Southwestern Medical Center 2021-05-31
NCT03961789 Assessment of the Satisfaction of Patient Undergoing Opioid Replacement Therapy Toward Their Management in Community Pharmacy https://ClinicalTrials.gov/show/NCT03961789 Recruiting University Hospital, Clermont-Ferrand 2019-09-30
NCT03947749 Linking Epigenomics With Prescription Opioid Abuse and High Impact Musculoskeletal Pain https://ClinicalTrials.gov/show/NCT03947749 Recruiting University of Florida 2022-06-30
NCT03936985 Validation of a Community Pharmacy-Based Prescription Drug Monitoring Program Risk Screening Tool https://ClinicalTrials.gov/show/NCT03936985 Recruiting University of Utah 2020-08-30
NCT03932799 Prevent Unsafe Opioid Prescribing https://ClinicalTrials.gov/show/NCT03932799 Enrolling by invitation University of Washington 2021-09-30
NCT03925610 Recovery of Ventilation After General Anesthesia in Morbidly Obese Patients https://ClinicalTrials.gov/show/NCT03925610 Recruiting Stanford University 2020-09-15
NCT03859778 Evaluation of Pharmacy Students’ Perception of Opioid / Opiate Dependence https://ClinicalTrials.gov/show/NCT03859778 Completed University Hospital, Clermont-Ferrand 2019-03-31
NCT03845699 Development of an Algorithm That Predicts Hypoventilation Due to an Opioid Overdose https://ClinicalTrials.gov/show/NCT03845699 Recruiting RTM Vital Signs, LLC 2020-05-14
NCT03743493 PCORnet Opioid Surveillance Study https://ClinicalTrials.gov/show/NCT03743493 Active, not recruiting Louisiana Public Health Institute 2019-04-15
NCT03685162 Observational Study to Evaluate Levomethadone Safety and Effectiveness in Subjects Under Opioid Maintenance Treatment https://ClinicalTrials.gov/show/NCT03685162 Recruiting L.Molteni & C. dei F.lli Alitti-Soc. di Esercizio S.p.A. 2023-02-28
NCT03635346 Medicinal Dependence and Chronic Pain: Addictive Evaluation in CETD https://ClinicalTrials.gov/show/NCT03635346 Completed University Hospital, Brest 2016-09-03
NCT03604861 An Observational Study of Environmental and SocioEconomic Factors in Opioid Recovery https://ClinicalTrials.gov/show/NCT03604861 Completed Indivior Inc. 2019-03-31
NCT03603158 KCNH2 Polymorphisms on the QTc Interval in Kelantanese Malays Patients Receiving Methadone Maintenance Therapy (MMT) https://ClinicalTrials.gov/show/NCT03603158 Completed Universiti Sains Malaysia 2012-12-31
NCT03583138 HIV, Buprenorphine, and the Criminal Justice System (STRIDE2) https://ClinicalTrials.gov/show/NCT03583138 Completed Yale University 2015-12-15
NCT03495388 PG and PK of Oxycodone to Personalize Post-op Pain Management Following Surgery in Children https://ClinicalTrials.gov/show/NCT03495388 Recruiting Indiana University 2020-03-31
NCT03427424 Imaging Biomarker for Addiction Treatment Outcome https://ClinicalTrials.gov/show/NCT03427424 Recruiting National Institutes of Health Clinical Center (CC) 2022-12-31
NCT03422211 A Prospective Assessment of Opioid Utilization Post-operatively in Sports Orthopaedic Surgeries https://ClinicalTrials.gov/show/NCT03422211 Active, not recruiting St. Louis University 2018-11-06
NCT01191242 Methadone Monitoring for Insights Into Adverse Events https://ClinicalTrials.gov/show/NCT01191242 Completed Intermountain Health Care, Inc. 2011-03-31
NCT01108679 Neurocognitive Effects of Buprenorphine Among HIV+ and HIV-Opioid Users https://ClinicalTrials.gov/show/NCT01108679 Completed Albert Einstein College of Medicine 2012-02-01
NCT00857350 The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist Treatment https://ClinicalTrials.gov/show/NCT00857350 Completed Yale University 2010-06-30
NCT02660606 A Qualitative Study to Assess the Content Validity of the Prescription Opioid Misuse and Abuse Questionnaire https://ClinicalTrials.gov/show/NCT02660606 Completed Member Companies of the Opioid PMR Consortium 2016-01-18
NCT02863601 Impact of Pregnancy on Buprenorphine Pharmacokinetics and Pharmacodynamics https://ClinicalTrials.gov/show/NCT02863601 Recruiting University of Pittsburgh 2021-06-30
NCT00687089 Examination of Cognitive Function in Patients Treated With Subutex https://ClinicalTrials.gov/show/NCT00687089 Completed BeerYaakov Mental Health Center 2009-01-31
NCT00725608 Acceptability and Safety of Switching From Subutex or Other Opioid Drug Dependence Therapy to Suboxone (NIS P05444) https://ClinicalTrials.gov/show/NCT00725608 Completed Indivior Inc. 2011-04-30
NCT00723749 Treatment of Opioid Dependent Patients With Suboxone: Acceptability & Safety Data From Real Life Scenario (Study P05603) https://ClinicalTrials.gov/show/NCT00723749 Completed Indivior Inc. 2010-12-31
NCT00723697 Observational Study of Misuse of High Dose Buprenorphine (Subutex® or Generic) in Opiate-Addicted Patients in France (Study P05186AM1)(COMPLETED) https://ClinicalTrials.gov/show/NCT00723697 Completed Indivior Inc. 2010-02-28
NCT00698737 Treatment Study: Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine (ARC) https://ClinicalTrials.gov/show/NCT00698737 Completed Wayne State University 2012-11-30
NCT00684840 Effects of Stress and Other Factors on Opiate Drug Choice. https://ClinicalTrials.gov/show/NCT00684840 Completed Wayne State University 2011-12-31
NCT00608504 Effects of Environmental Factors on Opiate Drug Choice in Opioid Dependent Individuals. https://ClinicalTrials.gov/show/NCT00608504 Completed Wayne State University 2009-04-30
NCT00473993 Hepatitis C Among Opioid Addicts in Opioid Maintenance Treatment in Zurich, Switzerland https://ClinicalTrials.gov/show/NCT00473993 Completed Seidenberg, Arztpraxis A., M.D. NA
NCT00471042 Study of Buprenorphine Maintenance Treatment for Opioid Dependence in Primary Care https://ClinicalTrials.gov/show/NCT00471042 Completed New York State Psychiatric Institute 2008-08-31
NCT00439049 Substance Abuse Pre-Treatment Screening Study https://ClinicalTrials.gov/show/NCT00439049 Recruiting The University of Texas Health Science Center, Houston 2021-06-30
NCT00429767 Sustained Release d-Amphetamine & Buprenorphine on Drug Seeking Behavior in Opioid & Cocaine Dependent Individuals https://ClinicalTrials.gov/show/NCT00429767 Completed Wayne State University 2010-01-31
NCT00292136 Real Time Assessment of Drug Craving, Use, and Abstinence During Outpatient: A Development and Feasibility Study https://ClinicalTrials.gov/show/NCT00292136 Completed National Institutes of Health Clinical Center (CC) NA
NCT00237406 Interactive Voice Response (IVR) for Methadone Patients https://ClinicalTrials.gov/show/NCT00237406 Completed Butler Hospital NA
NCT00227357 The CORE Buprenorphine Project - An HIV Primary Care Program Demonstration https://ClinicalTrials.gov/show/NCT00227357 Completed Ruth M. Rothstein CORE Center 2008-12-31
NCT00218621 The Effects of Methadone and Buprenorphine on Fetal Neurobehavior and Infant Neonatal Abstinence Syndrome - 1 https://ClinicalTrials.gov/show/NCT00218621 Completed Johns Hopkins University 2009-02-28
NCT00218361 Effects of Post-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals https://ClinicalTrials.gov/show/NCT00218361 Completed Wayne State University NA
NCT00218309 Effects of Pre-Session Supplemental Hydromorphone on Drug Seeking Behavior in Opioid Dependent Individuals https://ClinicalTrials.gov/show/NCT00218309 Completed National Institute on Drug Abuse (NIDA) NA
NCT00218010 Methadone Levels in Breast Milk of Women Taking Methadone for Opiate Addiction - 2 https://ClinicalTrials.gov/show/NCT00218010 Completed National Institute on Drug Abuse (NIDA) 2005-08-31
NCT00170339 Bone Density and Serum Testosterone in Male Methadone Maintained Patients https://ClinicalTrials.gov/show/NCT00170339 Completed Hennepin Healthcare Research Institute NA
NCT00067184 Fetal Neurobehavioral Development in Methadone Maintained Pregnancies https://ClinicalTrials.gov/show/NCT00067184 Completed Johns Hopkins University 2010-08-31
NCT00000265 Subjective Effects of Nitrous Oxide in Dental Patients - 17 https://ClinicalTrials.gov/show/NCT00000265 Completed University of Chicago 2002-01-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03161795 Addressing the Risks of Long-Term Opioid Therapy in Chronic Noncancer Pain https://ClinicalTrials.gov/show/NCT03161795 Completed Seoul National University 2018-01-19
NCT02969668 Interferon-free Antiviral Treatment of Chronic Hepatitis C Virus Infection Among Opioid-substituted Patients https://ClinicalTrials.gov/show/NCT02969668 Active, not recruiting Universitätsklinikum Hamburg-Eppendorf 2018-10-31
NCT03729388 Treatment for Opiate Addiction: Prognostic fActors of Responsiveness to Maintenance Treatment https://ClinicalTrials.gov/show/NCT03729388 Recruiting Nantes University Hospital 2021-03-01
NCT03611335 A Pragmatic Trial of the Consult for Addiction Treatment and Care in Hospitals (CATCH) Model for Engaging Patients in Opioid Use Disorder Treatment https://ClinicalTrials.gov/show/NCT03611335 Enrolling by invitation NYU Langone Health 2022-08-31
NCT03570099 Naloxone Treatment in Skåne County - Effect on Drug-related Mortality and Overdose-related Complications https://ClinicalTrials.gov/show/NCT03570099 Recruiting Region Skane 2020-07-01